List of Medical Device Companies in Canada - 27

7D Surgical is a privately-owned Toronto based company that develops advanced optical technologies and machine vision-based registration algorithms to improve surgical workflow and patient care. 7D Surgical's flagship FLASH Navigation System delivers profound improvement to surgical workflows in spine surgery, providing the promise of similar future advancements in other surgical specialties.

Cardiovascular solutions without compromise. BioIntegral Surgical, Inc. is focused on all-biological cardiovascular implants which are designed to last the lifetime of the patient. All BioIntegral Surgical devices are backed by a lifetime warranty, the only of its kind in the medical device industry. Balancing the most durable designs, biocompatible materials and quickest to implant devices, the implants are meant to eliminate the ordinary compromises and short-comings of other devices. Other devices don’t have permanently fixed tissue, leach toxic residuals, use synthetic materials or have cheaper-to-manufacture designs which compromise the redistribution of force and longevity. Company core values ------------------------------ Excellence. We commit to make the best, high-quality devices available globally Initiative. We value initiative to improve the capabilities of the company although not at the expense of quality Integrity. We strive for integrity in our decisions and products Ownership. We instill a sense of ownership for each employee Education. We aim to educate each other so we can make the best decisions and produce the best results together

Breathe BioMedical® is developing an innovative breath analytics platform to enable the early detection of disease. Our proprietary breath analytics technology is designed to collect, process and analyze breath samples to identify biomarker patterns associated with specific diseases. Breathe BioMedical is focused first on implementing a new breath test for breast cancer detection for women with dense breast tissue, as an adjunct to mammography, with the goal of increasing the number of breast cancer cases identified at the earliest stages. One day, detecting disease may be as easy as breathing.

Headquartered in Kickland, Quebec, ChitogenX Inc. (formally Ortho Regenerative Technologies Inc.) is a clinical stage regenerative medicine company dedicated to the development of novel therapeutic tissue repair technologies to improve tissue healing. The Company is committed to the clinical development of its proprietary RESTORE technology platform, a muco-adhesive CHITOSAN based biopolymer matrix, specifically designed to deliver biologics such as platelet-rich plasma (PRP) or bone marrow aspirate concentrate (BMAC), to enhance healing in various musculoskeletal conditions. ORTHO-R, its lead Chitosan-PRP hybrid biologic implant combination product, is formulated and designed to increase the healing rates of occupational and sports related injuries to tendons, ligaments, and cartilage such as the meniscus. ORTHO-R can be directly and easily applied to the site of injury by a surgeon during a routine operative procedure with minimal disruption to length of surgery. ORTHO-R is currently the object of an ongoing U.S. Phase I/II clinical trial for rotator cuff tear repair in 10 U.S. based clinical centers. Other formulations are being developed to leverage the technology's performance characteristics such as tissue adhesion, pliability, and ability to deliver biologics or therapeutics to various tissues damaged by trauma or disease. Further information about Chitogenx is available on the Company's website at www.chitogenx.com and on SEDAR at www.sedar.com.

Covalon is a leading provider of compassionate care solutions that help patients heal faster and live better. We are a patient-driven medical device company, with a strong portfolio of patented technologies and solutions for advanced wound care, infection prevention and medical device coatings. We offer innovative, gentler and more compassionate options for patients to heal with less infections, less pain and better outcomes, because we care.

Diros Technology Inc. is a world leader in the development and commercialization of Radiofrequency RF devices for Pain Management and Neurosurgery. The principals of Diros Technology Inc. have been at the forefront of Radiofrequency (RF) since the establishment of the OWL® brand in 1969. Diros was founded in 1983 to continue the advancement of new and innovative RF Products.

Fluid Biomed is a medical device start-up founded by two neurosurgeons at the University of Calgary that has developed an implantable dissolving stent to divert blood flow and heal blood vessels. The desire to innovate and create positive change has always been a priority for the founders and inventors, Dr. John Wong and Dr. Alim Mitha. Working together for the past 18 years to help people with stroke, their drive and commitment to improve patient health sparked a vision to create a radical new stent to cure brain aneurysms without invasive surgery.

We are Gemina Labs, a point-of-care test developer with a proprietary breakthrough chemistry platform. Founded in 2020, the Gemina chemistry platform is an advanced, “universal” bio-sensing toolkit that enables a new generation of diagnostic tests for infectious diseases and beyond. The chemistry platform isn’t just high-performing. It also overcomes many supply chain accuracy bottlenecks in the sector and cuts the development time for prototype tests to weeks. Best of all, the platform empowers “quantitative testing” (not just positive/negative tests) that opens up new applications in personal well-being (stress, fatigue monitoring etc.)

Based on world-leading technology, we are developing a unique ultrasound helmet that is as portable as it is precise. Our first disease target: Alzheimer’s disease.

HALIFAX BIOMEDICAL INC. (HBI) is a biomedical company focused on the delivery of contract research services and the development of diagnostic medical equipment. We are the only company worldwide currently providing a complete product and service solution for RSA. We support the fundamental principles of phased innovation - the practice of clinically testing products before general market release.

Innodem Neurosciences is committed to improving the effectiveness and quality of life and care of patients with neurological problems. Innodem works with the pharmaceutical industry, leading medical professionals, and artificial intelligence experts to develop and promote Eye Movement Biomarkers (EMBs) & Gaze Mapping Biomarkers (GMBs) as important clinical assessment tools in the field of neurology. It is building a series of disease-specific tests embodied in an intuitive App that captures EMB & GMB data. The vision is that over time, while leveraging the latest advances in machine and deep learning, this EMB/GMB platform will assist users to accurately diagnose and monitor neurological disorders affecting eye-movements or cognition such as multiple sclerosis, Alzheirmer's, Parkinson's or related disorders, Frontotemporal dementia, Cancer-related cognitive impairment (Chemo Brain) and many others.

Insight Medbotics is developing MRI-guided robotics to bring together the insights only MRI can provide with the minimally invasive access and precision of robotics. Our MRI-compatible robot, IGAR, has been clinically demonstrated. As the only company to receive a FDA 510(k) clearance for use of a robot inside an MRI, Insight Medbotics is now advancing the technology to improve the standard of care for prostate cancer. Our vision is to bring our advanced MRI-guided robotic technology to procedures where accuracy and precision matter most to patients, physicians and hospitals.

Izotropic is a Medical Imaging company that specializes in making Breast CT an indispensable tool for improving breast cancer outcomes.

Laborie is a world-class specialist medical company that makes and advances technologies that preserve and restore human dignity. We take great pride in supporting doctors, nurses, hospitals, clinics, academic institutions and patients with treatment and diagnostic innovations. Our technologies include diagnostic equipment and consumable supplies in the Urology, Gastroenterology, Gynecology, Obstetrics and Neonatology fields. Privately owned by Patricia Industries and a part of the Investor AB network, Laborie is comprised of powerful brands that have been cultivated for more than 50 years. As a rapidly growing and scaling organization, our company values drive our day-to-day behaviors and make us ONE Laborie whenever and wherever we do business. We know that the work we do matters and we’re making a positive impact in the lives of patients across the globe. This is what fuels our motivation each day. If you’re ready to be part of a mission with meaning and a rewarding environment with opportunities for professional growth and career advancement, view our current job openings at https://laborie.bamboohr.com/jobs/ and apply online.

MolecuLight Inc. a privately-owned medical imaging company that has developed and is commercializing its proprietary fluorescent imaging platform technology in multiple clinical markets. MolecuLight’s suite of commercially released devices, including the MolecuLight i:X® and DX™ fluorescence imaging systems and their accessories, provide point-of-care handheld imaging devices for the global wound care market for the real-time detection of wounds containing elevated bacterial burden > 10^4 CFU/g (when used with clinical signs and symptoms) and for digital wound measurement #moleculight

Ondine Biomedical is a life sciences company leading the charge in breakthrough photodisinfection-based therapies to prevent and treat serious infections, including those caused by existing, emerging, and antimicrobial-resistant pathogens. The company has created a patented, platform technology (photodisinfection) to provide simple solutions to complex infections across different therapeutic areas in healthcare and industry settings.

AN INSIDE OUT APPROACH TO PROSTATE ABLATION Profound Medical is a Canadian medical device company that has developed a unique and minimally invasive procedure to ablate the prostate gland in prostate cancer patients. Profound's novel technology combines real-time MR imaging with transurethral therapeutic ultrasound and closed-loop thermal feedback control. It provides a highly precise treatment tailored to patient-specific anatomy and pathology. This method of prostate ablation offers short treatment times and low morbidity, allowing for fast patient recovery. For more information, visit profoundmedical.com

A Canadian based medical device company building world's first minimally invasive heart pump for patients with advanced heart failure.

Radialis is advancing precision medicine by providing the next generation of organ-targeted positron emission tomography (PET).

At Rehabtronics, we make technology to help people recover from neurological injuries like stroke and spinal cord injury. Our products include the ReJoyce and ReTouch workstations for upper extremity rehabilitation, and the ReGrasp nerve stimulator for hand movement.

Satisfai Health is on a mission to create the most comprehensive AI solution for gastrointestinal (GI) practice and research. To realize this vision, we aim to enhance the quality, speed, and affordability of existing methods for the detection, diagnosis, assessment and treatment of disease. Satisfai Health's AI products cover a range of applications in Upper and Lower GI, delivering innovative measurement, tracking and reporting on the most important clinical findings. Our core focus is enhancing human experiences. Through technology, we deliver personalized and precise approaches that benefit both caregivers and patients. Our solutions are used by pharmaceutical companies and contract research organizations in the drug development process, and will be used by practicing GI physicians in clinical practice. Our team is composed of highly experienced physicians, data scientists, software engineers and healthcare business professionals. We work with a network of globally recognized scientific and clinical experts, and are fortunate to be supported by some of the world's leading venture capital and private equity groups. We are growing quickly and always looking to add high quality talent in the right areas.

Sonic Incytes is committed to enhancing patient care through innovative diagnostic solutions. The company's flagship product, Velacur™, equips physicians with an advanced liver imaging tool to help manage the growing epidemic of fatty liver disease. Velacur offers real-time, AI guided quantification of the two key markers for fatty liver disease: liver stiffness and attenuation. With real-time results, a low up-front cost and AI guidance, VELACUR makes liver imaging at the point of care affordable and accessible.

SoundBite is a medical devices start-up, Montreal and Sherbrooke-based, developing and commercializing proprietary shockwave device and generator technology delivered within the cardiovascular system to treat chronic total occlusions (CTO's). The company will target CTO's in patients with peripheral artery disease (PAD) and coronary artery disease (CAD), disease states that affect over 12 million and 8 million Americans, respectively.

Sound Blade Medical is developing a compact ultrasound therapy platform that will allow a variety of pathologies to be treated non-invasively with unparalleled precision.

StarFish Medical provides award-winning design, development, and flexible manufacturing outsourcing services —100% dedicated to the medical device and life science marketplace. StarFish partners with innovative companies to create and manufacture breakthrough products for a full range of medical specialty areas including: Cardiovascular, Digital Health, IVD, Ophthalmology, Optics, Ultrasound, POC Assay Diagnostic Technologies, and Microfluidics. StarFish expertise includes electronics, mechanical, human factors and software systems engineering. Our proprietary Pathfinder™ process for medical device product definition saves clients time and resources throughout the technology and product development phases to commercialization. Prototype and low volume complex electro-mechanical production are delivered in ISO 13485 certified facilities with cleanroom capabilities in Toronto and Victoria Regulatory and quality system (QMS) consultants at StarFish provide technical regulatory assistance for FDA and Health Canada submissions, including IEC 60601 and ISO13485. Innovative Design and Development  Electronic / software / mechanical engineering  Industrial design / human factors engineering  PathfinderTM product definition process  Technology optimization  Verification / validation / testing  ISO 13485 certified QMS Integrated Manufacturing  Seamless ramp from clinical trials to full production  Deep engineering involvement & oversight  Electro-mechanical / software expertise  Customized cart specialists  Optical instrument build and test  Dedicated program manager Flexible Manufacturing  New product introductions  Supply-chain management  North America facilities  Depot repair & field service  Sustaining / value engineering  Class 100,000 cleanroom

Interested in working at Synex? Connect with us https://careers.synexmedical.com/ Our mission is to make predictive health a reality by providing accurate and non-invasive monitoring at the molecular level. Non-invasive glucose monitoring has been sought after for decades. Many people have tried. None have succeeded. Our novel approach to solving and going beyond this challenge will enable a future of true predictive healthcare. We’re looking for passionate and exceptionally talented people who want to be part of the team that achieves this vision.

Zilia is a health technology company developing a breakthrough platform to measure biomarkers in the eye, with an initial focus on ocular oximetry.